We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Transfusions During Surgery May Increase Risk of Pneumonia

By HospiMedica International staff writers
Posted on 10 Feb 2015
Patients who receive red blood cell (RBC) transfusions during coronary artery bypass grafting (CABG) surgery are at an increased risk of developing pneumonia, according to a new study.

Researchers at the University of Michigan Health System (Ann Arbor, USA) examined data on 16,182 patients who underwent CABG surgery between 2011 and 2013 in 33 hospitals participating in the Michigan Society of Thoracic and Cardiovascular Surgeons Quality Collaborative. More...
Among participants in the study group, 39.9% received RBC transfusions and 3.6% developed pneumonia, with a significant association found between RBC transfusion and the occurrence of pneumonia.

The researchers found that risk of developing pneumonia increased with volume of RBC transfused; patients receiving one or two units of RBCs had double the odds of developing pneumonia compared to patients not receiving transfusion, while those who received six units or more had a 14-fold increased odds of developing pneumonia. The dose-dependent relationship was consistent across clinical subgroups and was not affected by other blood products, such as platelets. The study was presented at the annual meeting of the Society of Thoracic Surgeons (STS), held during January 2015 in San Diego (CA, USA).

“Pneumonia is a known risk following CABG surgery, and developing it has been shown to significantly increase a patient's risk of morbidity and mortality,” said lead author and study presenter Donald Likosky, PhD. “Patients should receive red blood cell transfusions based on clinical need. Surgical teams may have opportunities to reduce the need for transfusions among patients, thereby reducing the risk of secondary complications.”

Blood transfusions may cause transient immune suppression, thus increasing the susceptibility to infection, although the mechanism remains elusive. Another concern is that after transfusion macrophages lose their migratory ability in response to chemotactic stimuli, and also produce more prostaglandin. There is also an association between the length of storage of transfused RBCs and postoperative pneumonia, since various immunosuppressive substances are released from white blood cell granules during blood storage, contributing to transfusion-induced immunomodulation.

Related Links:

University of Michigan Health System



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Medical Examination & Procedure Light
Vega 80
Desk Aneroid Sphyg
Diagnostix 750D+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image: Lead study author Ramy Ghanim (left) and co-author Joy Jackson test an small implantable device alongside Assistant Professor Alex Abramson. In a new Science paper, they describe a networking system that connects therapeutic implants and wearable devices by using the body’s natural conductivity to send tiny signals. (Photo courtest of Georgia Tech)

Bioelectronic Network Enables Devices to Communicate Through Body Tissue and Coordinate Therapy

Wearable sensors and implanted therapeutic devices can be difficult to coordinate when signals must pass through the body. Conventional wireless signals do not travel well through tissue, while the antennas... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.